Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pet-ct”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03947892
What this trial is testing

Predictive Value of PET CT in the Histologic Lymph Node Status of Patients With Squamous Cell Carcinoma of the Oral N0 Clinical and Radiological Cavity.

Who this might be right for
Squamous Cell Carcinoma of the OralClinically Node-Negative and Radiology
University Hospital, Grenoble 40
Not applicableStudy completedNCT02018107
What this trial is testing

PET/CT-Assessment of Liver Tumor Ablation

Who this might be right for
Liver TumorLiver Neoplasms
Dana-Farber Cancer Institute 33
Not applicableNot Yet RecruitingNCT06957782
What this trial is testing

The Value of 68Ga-FAPI PET/CT for Evaluating Peritoneal Treatment Response

Who this might be right for
Peritoneal MetastasisFAPI
Erasmus Medical Center 16
Early research (Phase 1)Ended earlyNCT02809690
What this trial is testing

18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer

Who this might be right for
Prostate Neoplasm
University of Southern California 18
Not applicableUnknownNCT00782691
What this trial is testing

Validation of FDG-PET Segmentation Tools for Tumor Delineation by Correlation of CT- and FDG-PET Volume Measurements With Histopathology of Nodal Metastases of Head and Neck Carcinomas.

Who this might be right for
Head and Neck Cancer
Radboud University Medical Center 15
Not applicableStudy completedNCT03376360
What this trial is testing

Functional Medical Imaging Quantization in Prostate Cancer

Who this might be right for
Prostate Cancer
University Hospital, Brest 61
Not applicableStudy completedNCT03576040
What this trial is testing

Whole Body Dynamic 68Ga-DOTATOC PET/CT in Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
University Hospital, Brest 120
Not applicableStudy completedNCT01219985
What this trial is testing

Benefits Study of Respiratory-gated Positron Emission Tomography Acquisitions of the Liver

Who this might be right for
Liver Cancer
Centre Hospitalier Universitaire, Amiens 50
Testing effectiveness (Phase 2)Ended earlyNCT02078843
What this trial is testing

Diagnostic Accuracy of Gallium-68-DOTATATE PET/CT Compared to Indium-111-pentetreotide Scintigraphy (SPECT/CT) for Gastroenteropancreatic Neuroendocrine Tumors

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumors
Insel Gruppe AG, University Hospital Bern 54
Large-scale testing (Phase 3)Study completedNCT02260817
What this trial is testing

Expanded Access to Diagnostic Imaging for Staging of Recurrent Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Global Isotopes, LLC d/b/a Zevacor Molecular 109
Early research (Phase 1)Study completedNCT02134639
What this trial is testing

PET-CT Imaging of Neuro-endocrine Tumors and Preliminary Clinical Evaluation

Who this might be right for
Neuroendocrine Tumors
University Hospital, Bordeaux 20
Not applicableUnknownNCT06205901
What this trial is testing

Comparison Study Between PET/CT and Whole-Body Diffusion Weighted MRI in the Detection of Distant Malignancies

Who this might be right for
Distant Metastasis
Sohag University 50
Not applicableEnded earlyNCT01889212
What this trial is testing

Imaging With 11C-erlotinib PET/CT to Identify Responders to Erlotinib Treatment in NSCLC

Who this might be right for
Lung Cancer
University of Aarhus 4
Not applicableLooking for participantsNCT06834412
What this trial is testing

A Study Evaluating the Value of 68Ga-Pentixafor PET Imaging in the Staging of Hematological Tumor, and Comparing It with 18F-FDG PET/CT Imaging

Who this might be right for
Hematological Malignancies
Xijing Hospital 120
Not applicableStudy completedNCT03000972
What this trial is testing

PFN-A Augmentation for Intertrochanteric Femoral Fractures

Who this might be right for
Intertrochanteric Fracture
Uppsala University 20
Not applicableUnknownNCT06677775
What this trial is testing

Pathological Positivity Rate in Prostate Cancer Patients with PI-RADS 4 and First Negative Biopsy

Who this might be right for
Prostate Cancer
Anhui Provincial Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07770672
What this trial is testing

An Exploratory Clinical Study of Accurate Efficacy Assessment of Neoadjuvant Immunotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma Based on 68Ga-FAPI ([68Ga] Fibroblast Activation Protein Inhibitor)/¹⁸F-FDG (2-Deoxy-2-[¹⁸F]Fluoro-D-glucose) Dual Imaging

Who this might be right for
Esophageal CancerESCC
Tan Lijie 92
Not applicableLooking for participantsNCT05775939
What this trial is testing

PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial

Who this might be right for
Lung CarcinomaEsophageal Carcinoma
Thomas Jefferson University 20
Not applicableStudy completedNCT04073875
What this trial is testing

18F-GP1 PET-CT to Detect Bioprosthetic Aortic Valve Thrombosis

Who this might be right for
Thrombosis CardiacAortic Valve Disease
University of Edinburgh 53
Testing effectiveness (Phase 2)Looking for participantsNCT07325253
What this trial is testing

A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Graft Versus Host Disease Manifestations

Who this might be right for
Pilot StudyPET/CT ImagingHost Disease Manifestation
M.D. Anderson Cancer Center 16
Next Page